Cannabis-based spray for MS could be out next month

摘要

A cannabis-based medicine for the treatment of muscle pain in multiple sclerosis could be available in the UK next month. Sativex (tetrahydrocannabinol, cannabidiol; GW Pharmaceuticals) is currently in the final stages of approval by the Medicines and Healthcare products Regulatory Agency for marketing in the UK, a spokesman for GW Pharmaceuticals told The Journal.